CIK 0001815442 · Large accelerated filer
Kymera Therapeutics, Inc.
Sign in to watch- Ticker
- KYMR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 812992166
- Phone
- 857-285-5314
- Business address
- 500 NORTH BEACON STREET, 4TH FLOOR, WATERTOWN, MA, 02472
- Former names
- Kymera Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $4,158,214
- in 2 filings, $3.4M under 10b5-1 plans
Net −$4,158,214. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-25 | Booth Bruce Director | Sale 10b5-1 | −9,229 | $114.65 | $1.1M | 3,296,147 |
| 2026-06-25 | Booth Bruce Director | Sale 10b5-1 | −58,205 | $115.57 | $6.7M | 3,237,942 |
| 2026-06-25 | Booth Bruce Director | Sale 10b5-1 | −81,500 | $116.53 | $9.5M | 3,156,442 |
| 2026-06-25 | Booth Bruce Director | Sale 10b5-1 | −24,268 | $117.50 | $2.9M | 3,132,174 |
| 2026-06-25 | Booth Bruce Director | Sale 10b5-1 | −19,089 | $118.60 | $2.3M | 3,113,085 |
| 2026-06-25 | Booth Bruce Director | Sale 10b5-1 | −1,399 | $107.30 | $150K | 595,648 |
| 2026-06-25 | Booth Bruce Director | Sale 10b5-1 | −23 | $108.02 | $2K | 595,625 |
| 2026-06-25 | Booth Bruce Director | Sale 10b5-1 | −2,011 | $108.83 | $219K | 593,614 |
| 2026-06-25 | Booth Bruce Director | Sale 10b5-1 | −265 | $110.30 | $29K | 593,349 |
| 2026-06-25 | Booth Bruce Director | Sale 10b5-1 | −86 | $110.79 | $10K | 593,263 |
| 2026-06-25 | Booth Bruce Director | Sale 10b5-1 | −100 | $111.89 | $11K | 593,163 |
| 2026-06-25 | Booth Bruce Director | Sale 10b5-1 | −1,437 | $113.70 | $163K | 591,726 |
| 2026-06-25 | Booth Bruce Director | Sale 10b5-1 | −1,289 | $114.65 | $148K | 590,437 |
| 2026-06-25 | Booth Bruce Director | Sale 10b5-1 | −8,389 | $115.57 | $970K | 582,048 |
| 2026-06-25 | Booth Bruce Director | Sale 10b5-1 | −11,375 | $116.53 | $1.3M | 570,673 |
| 2026-06-25 | Booth Bruce Director | Sale 10b5-1 | −3,359 | $117.50 | $395K | 567,314 |
| 2026-06-25 | Booth Bruce Director | Sale 10b5-1 | −2,646 | $118.60 | $314K | 564,668 |
| 2026-06-25 | Goodman Noah Chief Business Officer | Option exercise 10b5-1 | +5,000 | $21.05 | $105K | 55,195.44 |
| 2026-06-25 | Goodman Noah Chief Business Officer | Sale 10b5-1 | −2,500 | $109.00 | $273K | 52,695.44 |
| 2026-06-25 | Goodman Noah Chief Business Officer | Sale 10b5-1 | −2,500 | $119.00 | $298K | 50,195.44 |
Page 7 of 25 · 493 trades